This billionaire’s cancer moonshot is falling far short of the hype https://t.co/PKaDr7a4HQ
— The Propell Group (@ThePropellGroup) February 16, 2017
#healthtech
This billionaire’s cancer moonshot is falling far short of the hype https://t.co/PKaDr7a4HQ
— The Propell Group (@ThePropellGroup) February 16, 2017
#healthtech